Cited by 602HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Open access

Liu, Albert Y., Cohen, Stephanie E., Vittinghoff, Eric, Anderson, Peter L., Doblecki-Lewis, Susanne, Bacon, Oliver, Chege, Wairimu, Postle, Brian S., Matheson, Tim, Amico, K. Rivet, Liegler, Teri, Rawlings, M. Keith, Trainor, Nikole, Blue, Robert Wilder, Estrada, Yannine, Coleman, Megan E., Cardenas, Gabriel, Feaster, Daniel J., Grant, Robert, Philip, Susan S., Elion, Richard, Buchbinder, Susan, Kolber, Michael A.·2016·JAMA Internal Medicine

DOI 10.1001/jamainternmed.2015.4683PMC PMC5042323

Open this paper in CoChat — free account Open PDF

Abstract

IMPORTANCE: Several randomized clinical trials have demonstrated the efficacy of preexposure prophylaxis (PrEP) in preventing human immunodeficiency virus (HIV) acquisition. Little is known about adherence to the regimen, sexual practices, and overall effectiveness when PrEP is implemented in clinics that treat sexually transmitted infections (STIs) and community-based clinics serving men who have sex with men (MSM). OBJECTIVE: To assess PrEP adherence, sexual behaviors, and the incidence of STIs and HIV infection in a cohort of MSM and transgender women initiating PrEP in the United States. DESIGN, SETTING, AND PARTICIPANTS: Demonstration project conducted from October 1, 2012, through February 10, 2015 (last date of follow-up), among 557 MSM and transgender women in 2 STI clinics in San Francisco, California, and Miami, Florida, and a community health center in Washington, DC. Data were analyzed from December 18, 2014, through August 8, 2015. INTERVENTIONS: A combination of daily, oral tenofovir disoproxil fumarate and emtricitabine was provided free of charge for 48 weeks. All participants received HIV testing, brief client-centered counseling, and clinical monitoring. MAIN OUTCOMES AND MEASURES: Concentrations of tenofovir diphosphate in dried blood spot samples, self-reported numbers of anal sex partners and episodes of condomless receptive anal sex, and incidence of STI and HIV acquisition. RESULTS: Overall, 557 participants initiated PrEP, and 437 of these (78.5%) were retained through 48 weeks. Based on the findings from the 294 participants who underwent measurement of tenofovir diphosphate levels, 80.0% to 85.6% had protective levels (consistent with ≥4 doses/wk) at follow-up visits. African American participants (56.8% of visits; P = .003) and those from the Miami site (65.1% of visits; P < .001) were less likely to have protective levels, whereas those with stable housing (86.8%; P = .02) and those reporting at least 2 condomless anal sex partners in the past 3 months (88.6%; P = .01) were more likely to have protective levels. The mean number of anal sex partners declined during follow-up from 10.9 to 9.3, whereas the proportion engaging in condomless receptive anal sex remained stable at 65.5% to 65.6%. Overall STI incidence was high (90 per 100 person-years) but did not increase over time. Two individuals became HIV infected during follow-up (HIV incidence, 0.43 [95% CI, 0.05-1.54] infections per 100 person-years); both had tenofovir diphosphate levels consistent with fewer than 2 doses/wk at seroconversion. CONCLUSIONS AND RELEVANCE: The incidence of HIV acquisition was extremely low despite a high incidence of STIs in a large US PrEP demonstration project. Adherence was higher among those participants who reported more risk behaviors. Interventions that address racial and geographic disparities and housing instability may increase the impact of PrEP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.4683

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citation
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Preexposure Prophylaxis for HIV Infection among African Women
Damme, L. V., Corneli, A. L., Ahmed, K., Agot, K. E., Lombaard, J. J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R. N., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,633
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapía, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,229
Regression models for ordinal responses: a review of methods and applications
Ananth, C. V. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.6.1323 · Cited by 594
Diagnoses of HIV infection in the United States and dependent areas, 2012
Siddiqi, A.-E.-A., Cohen, S. M., Johnson, A. S., Hu, X., Li, J., Patala, A., Wu, B., Guo, X., Dasari, S. R., Hall, I., et al. (2014) · Cited by 429

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 6

[4]McCormack S Dunn D Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study [Abstract 22LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[5]Molina JM Capitant C Spire B On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial [Abstract 24LB] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015 2015
[40]Liu A Developing and Implementing a Mobile Health (mHealth) Adherence Support System for HIV-Uninfected Men who have Sex with Men (MSM) Taking Pre-Exposure Prophylaxis (PrEP): The iText Study 8th International Conference on HIV Treatment and Prevention Adherence; [AB 229] Miami, FL June 2-4, 2013
[42]Scott H Vittinghoff E Irvin R Sex Pro: A Personalized HIV Risk Assessment Tool for Men Who Have Sex With Men [Abstract 1017] Conference on Retroviruses and Opportunistic Infections (CROI) Seattle, WA February 23-26, 2015
[43]Vallabhaneni S Hartogensis W Sheon N Harnessing mobile health technology in HIV research: a pilot study utilizing a smartphone-based daily-diary app to collect event-level sexual activity data [Abstract TUPE358] 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention 2013 Kuala Lampur, Malaysia
[46]Cohen SE Vittinghoff E Doblecki-Lewis S Response to “Race and the public health impact potential of PrEP in the United States” J Acquir Immune Defic Syndr 2015 PMC4558271 26049284

Sorted by citations

Items 401–500 of 599

NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand
Azariah, S., Saxton, P. J. W., Franklin, R., Forster, R. F., Werder, S. F., & Jenkins, R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026363 · Cited by 8
Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative
Martin, E. G., MacDonald, R. H., Gordon, D. E., Swain, C.-A. E., O’Donnell, T., Helmeset, J., Dwicaksono, A., & Tesoriero, J. M. (2020) · Public Health Reports · doi:10.1177/0033354920935069 · Cited by 7
Adherence and persistence of HIV pre‐exposure prophylaxis use in the United States
McCormick, C. D., Sullivan, P. S., Qato, D. M., Crawford, S. Y., Schumock, G. T., & Lee, T. A. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5729 · Cited by 12
Evaluation of a community-informed multimedia intervention to increase PrEP awareness and intention among African American young adults
Kerr, J., Combs, R. M., Sterrett-Hong, E., Harris, L. M., Northington, T., Krigger, K. W., & Parker, K. (2024) · AIDS Care · doi:10.1080/09540121.2023.2297739 · Cited by 7
Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study
Baltes, V., de Boissieu, P., Champenois, K., Luan, L., Seng, R., Essat, A., Novelli, S., Spire, B., Molina, J., Goujard, C., et al. (2024) · Journal of the International AIDS Society · doi:10.1002/jia2.26226 · Cited by 9
Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada
Rajchgot, J., Siemieniuk, R. A. C., Sivachandran, N., Murphy, P., Sharp, A., Cicci, A., & Bogoch, I. I. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001004 · Cited by 7
Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States
Towe, S. L., Sullivan, C. A., McKellar, M., & Meade, C. S. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02987-y · Cited by 7
Tenofovir Diphosphate in Dried Blood Spots in Pregnant and Postpartum Women With HIV in Kenya: A Novel Approach to Measuring Peripartum Adherence
Abuogi, L., Castillo‐Mancilla, J., Hampanda, K., Owuor, K. O., Odwar, T., Onono, M. A., Helová, A., Turan, J. M., & Anderson, P. L. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002859 · Cited by 7
Cost-Effectiveness of Interventions to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence, and Persistence Among Men Who Have Sex With Men
Wheatley, M. M., Knowlton, G., Kao, S.-Y., Jenness, S. M., & Enns, E. A. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002921 · Cited by 7
Predictors of PrEP retention in at risk patients seen at a HIV primary care clinic in San Diego
Herns, S. D., Panwala, R., Pfeil, A., Sardinha, M., Rossi, V., Blumenthal, J. S., & Hill, L. A. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231179276 · Cited by 7
Current challenges in the clinical management of sexually transmitted infections
de Vries, H. J. C. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25347 · Cited by 6
“Shades of risk”: Understanding current PrEP users’ sexually transmitted infection perceptions
Klasko-Foster, L. B., Wilson, K., Bleasdale, J., Gabriel, S. J., & Przybyla, S. (2021) · AIDS Care · doi:10.1080/09540121.2021.1957762 · Cited by 7
What makes an optimal delivery for PrEP against HIV: A qualitative study in MSM
Lau, J. Y. C., Wong, N. S., Lee, K. C. K., Kwan, T. H., Lui, G. C.-Y., Chan, D. P. C., & Lee, S. S. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624211060824 · Cited by 7
Sexually transmitted infections among participants in an HIV PrEP adherence trial
Bristow, C., Hassan, A., Moore, D. J., Dubé, M. P., Corado, K., Chow, K., Ellorin, E. E., Blumenthal, J. S., Morris, S., & The CCTG Team (2022) · International Journal of STD & AIDS · doi:10.1177/09564624211053428 · Cited by 7
Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System—A Cohort Study
Hechter, R. C., Bruxvoort, K. J., Zhou, H. C., Towner, W. J., Contreras, R., Schumacher, C. M., Grant, D. L., & Jones, J. L. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003015 · Cited by 7
Retention in event-driven PrEP among young Thai men who have sex with men at risk of HIV acquisition
Traikiatphum, J., Wongharn, P., Moonwong, J., Songtaweesin, W. N., Vitsupakorn, S., Premgamone, A., Kawichai, S., & Puthanakit, T. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624221106527 · Cited by 7
Acceptability and tolerability of and adherence to HIV preexposure prophylaxis among Toronto gay and bisexual men: a pilot study
Tan, D. H. S., Schnubb, A., Lawless, J., Szadkowski, L., Grennan, T., Wilton, J., Fowler, S., Hart, T. A., Maxwell, J., & Raboud, J. (2018) · CMAJ Open · doi:10.9778/cmajo.20180068 · Cited by 7
Impact of sexual trajectories of men who have sex with men on the reduction in HIV transmission by pre-exposure prophylaxis
Rozhnova, G., Heijne, J. C. M., Basten, M., den Daas, C., Matser, A. A., & Kretzschmar, M. (2019) · Epidemics · doi:10.1016/j.epidem.2019.03.003 · Cited by 7
Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study
Shrestha, R., Altice, F. L., Sibilio, B., Ssenyonjo, J., & Copenhaver, M. M. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.06.012 · Cited by 7
Mapping the Study Characteristics and Topics of HIV Pre-Exposure Prophylaxis Research Literature: A Scoping Review
Kamitani, E., Mizuno, Y., Wichser, M. E., Adegbite, A. H., DeLuca, J. B., & Higa, D. H. (2019) · AIDS Education and Prevention · doi:10.1521/aeap.2019.31.6.505 · Cited by 7
HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers
Kutscha, F., Gaskins, M. D., Sammons, M. K., Nast, A., & Werner, R. N. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00298 · Cited by 8
Added Benefits of Pre-Exposure Prophylaxis Use on HIV Incidence with Minimal Changes in Efficiency in the Context of High Treatment Engagement Among Men Who Have Sex with Men
Singleton, A. L., Marshall, B. D. L., Zang, X., Nunn, A. S., & Goedel, W. C. (2020) · AIDS Patient Care and STDs · doi:10.1089/apc.2020.0151 · Cited by 7
Game Plan—a Brief Web-Based Intervention to Improve Uptake and Use of HIV Pre-exposure Prophylaxis (PrEP) and Reduce Alcohol Use Among Gay and Bisexual Men: Content Analysis
Wray, T. B., Chan, P. A., Guigayoma, J. P., & Kahler, C. W. (2021) · JMIR Formative Research · doi:10.2196/30408 · Cited by 7
Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex With Men in San Francisco County: The Importance of Rapid Return to Normalcy
Liang, C., Suen, S., Nguyen, A., Moucheraud, C., Hsu, L. C., Holloway, I. W., Charlebois, E. D., & Steward, W. T. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003156 · Cited by 6
Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection
Baeten, J. M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw224 · Cited by 6
Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis via CiteSpace
Chen, X., & Lai, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1099132 · Cited by 6
Syphilis for dermatologists: Current concepts
Navarrete, J., & Saavedra-Portales, S. (2023) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2023.12.009 · Cited by 6
Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States
Paschen-Wolff, M. M., Tross, S., Nelson, C. M., Hatch, M. A., Meche, D., Ertl, M. M., Wright, L., & Laschober, T. C. (2024) · AIDS Care · doi:10.1080/09540121.2024.2438923 · Cited by 6
A cohort analysis of sexually transmitted infections among different groups of men who have sex with men in the early era of HIV pre-exposure prophylaxis in France
Psomas, C. K., Pénaranda, G., Rétornaz, F., Khiri, H., Delord, M., Halfon, P., & Philibert, P. (2022) · Journal of Virus Eradication · doi:10.1016/j.jve.2022.100065 · Cited by 6
Sexual alcohol expectancies moderate the relation between alcohol use and sexual behavior among men who have sex with men
Murray, G. E., Palfai, T. P., Kratzer, M. P. L., Maisto, S. A., & Simons, J. S. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.12.005 · Cited by 6
Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care
Kenison, T. C., Badenhop, B. P., & Safo, S. A. (2020) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0288 · Cited by 6
Attitude of infectious diseases physicians in Turkey about HIV pre-exposure prophylaxis: results of an online survey
Çimen, C., Emecen, A. N., & Barber, T. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462420921080 · Cited by 7
Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections
Clement, M. E., Nicchitta, M., Sun, Y. J., Ellis, A. M., Chakraborty, H., McGee, K. S., Eagle, C., Frye, J. K., Taylor, D., Okeke, N. L., et al. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001288 · Cited by 6
Adherence to Daily Oral TDF/FTC for PrEP in Community Health Center Populations: The Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study
Smith, D. K., Rawlings, M. K., Glick, N. R., Mena, L. A., Coleman, M. E., Houlberg, M., McCallister, S. H., & Wiener, J. B. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03388-5 · Cited by 6
Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
Aizire, J., Brooks, K. M., Mirochnick, M. H., Flynn, P. M., Butler, K., Kiser, J. J., Siberry, G. K., Fenton, T., Cababasay, M. P., Fowler, M. G., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002247 · Cited by 6
Impact of Social Determinants of Health on Pre-Exposure Prophylaxis Care for HIV Prevention
Chan, P. A., Goedel, W. C., Li, Y., Mena, L. A., Patel, R. R., Marshall, B. D. L., Malyuta, Y., Ward, L. M., Underwood, A., Johnson, C. J., et al. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003601 · Cited by 5
Game Plan, a Web-Based Intervention to Improve Adherence and Persistence to HIV Pre-exposure Prophylaxis and Reduce Heavy Drinking in Gay, Bisexual, and Other Men Who Have Sex With Men: Usability and User Experience Testing
Wray, T. B., Chan, P. A., & Kahler, C. W. (2021) · JMIR Formative Research · doi:10.2196/31843 · Cited by 5
Integrating Enhanced HIV Pre-exposure Prophylaxis Into a Sexually Transmitted Infection Clinic in Lilongwe: Protocol for a Prospective Cohort Study
Rutstein, S. E., Matoga, M., Chen, J. S., Mathiya, E., Ndalama, B., Nyirenda, N., Bonongwe, N., Chithambo, S., Chagomerana, M., Tegha, G., et al. (2022) · JMIR Research Protocols · doi:10.2196/37395 · Cited by 5
Low Self-Perceived Need for PrEP and Behavioral Indications of MSM Who Recently Refused Daily PrEP: A Mixed Methods Study in Three U.S. Cities
Kota, K. K., Gelaude, D., Carnes, N., Schoua‐Glusberg, A., Frew, P. M., Randall, L. A., Gale, B., Betley, V., & Mansergh, G. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04276-4 · Cited by 4
Pre-Exposure Prophylaxis for the Prevention of HIV-1: An Assessment of Oral Pre-Exposure Prophylaxis Usage Patterns, First Evidence of HIV-1, and HIV-1 Risk Factors in the United States
Oglesby, A. K., Germain, G., Metzner, A. A., Laliberté, F., MacKnight, S. D., Hilts, A., Swygard, H., & Duh, M. S. (2024) · AIDS Patient Care and STDs · doi:10.1089/apc.2024.0158 · Cited by 5
The mChoice App, an mHealth Tool for the Monitoring of Preexposure Prophylaxis Adherence and Sexual Behaviors in Young Men Who Have Sex With Men: Usability Evaluation
Santos, F. C. D., Brin, M., Tanner, M. R., Galindo, C. A., & Schnall, R. (2025) · JMIR Human Factors · doi:10.2196/59780 · Cited by 5
Determinants of Pre-Exposure Prophylaxis (Prep) Persistence in a High-Risk Population in Central Florida
Keyes, J., Crouse, E., DeJesus, E., & Rolle, C.-P. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001352 · Cited by 5
The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs
Zimmerman, R. S., Mehrotra, P., Madden, T. E., & Paul, R. A. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00560-3 · Cited by 5
Is Tailoring of PrEP Programs Needed to Overcome Racial Disparities in PrEP Uptake in Local Health Departments? A Mixed-Methods Evaluation of PrEP Implementation in Virginia
Schexnayder, J. K., Elamin, F., Mayes, E., Cox, L., Martin, E., & Webel, A. R. (2022) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001463 · Cited by 5
The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study
Dahlby, L., Boyd, J., Knight, R., Philbin, M. M., Small, W., Kerr, T. H., & McNeil, R. (2022) · AIDS Care · doi:10.1080/09540121.2022.2085868 · Cited by 5
Prevalence of renal and bone risk factors among individuals prescribed oral pre-exposure prophylaxis for HIV
Fields, S. D., Gruber, J., Clue, J., Rey, G. G., & Cuervo, H. (2023) · IJID Regions · doi:10.1016/j.ijregi.2023.01.004 · Cited by 4
A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
Pereira, M., & Vale, N. (2023) · International Journal of Translational Medicine · doi:10.3390/ijtm3040032 · Cited by 5
Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022
Tao, G., Patel, C. G., He, L., & Workowski, K. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae314 · Cited by 5
Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention
Thomson, K. A., Haberer, J. E., Marzinke, M. A., Mujugira, A., Hendrix, C. W., Celum, C., Ndase, P., Ronald, A., Bangsberg, D. R., Baeten, J. M., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001356 · Cited by 5
Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings
Tao, G., Pearson, W. S., Sullivan, J. M., Henk, H. J., & Gift, T. L. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001339 · Cited by 5
Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission
Whiteside-Mansell, L., Sockwell, L., Knight, D. A., & Crone, C. C. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03219-7 · Cited by 6
Pre-Exposure Prophylaxis Among Gay, Bisexual, and Other Men Who Have Sex With Men in Ottawa: A Real World View With Benefits Beyond HIV Risk Reduction
Razmjou, S., Charest, M., O’Byrne, P., & MacPherson, P. A. (2021) · International Journal of Sexual Health · doi:10.1080/19317611.2021.1946731 · Cited by 6
Individual, Interpersonal, and Structural Factors That Influence Intentions to Use Pre-exposure Prophylaxis Among Sexual Minority Men in Miami
Rogers, B. G., Harkness, A., Satyanarayana, S., Pachankis, J. E., & Safren, S. A. (2022) · Archives of Sexual Behavior · doi:10.1007/s10508-021-02263-7 · Cited by 5
Lessons Learned From the Implementation of a Pilot Study on Self-collected Specimen Return by Sexual Minority Men (Project Caboodle!): Qualitative Exploration
Sallabank, G., Stephenson, R. B., Gandhi, M., Merrill, L., & Sharma, A. (2023) · JMIR Formative Research · doi:10.2196/43539 · Cited by 5
Sexually transmissible infection control programs for men who have sex with men – what will they look like in 2020?
Refugio, O. N., Roberts, C. P., West, R., & Klausner, J. D. (2016) · Sexual Health · doi:10.1071/sh16038 · Cited by 5
HIV/AIDS treatment funding system to support the people affected by HIV/AIDS in Surakarta, Indonesia
Demartoto, A., Murti, B., & Zunariyah, S. (2021) · SAHARA-J Journal of Social Aspects of HIV/AIDS · doi:10.1080/17290376.2020.1858946 · Cited by 8
Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS
Tesoriero, J. M., Yuan, Y., Newport, R., O’Grady, T. J., Cotroneo, R. A., Stevens, L. C., Grisham, T. M., Seo, S., & Gonzalez, C. J. (2022) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001554 · Cited by 5
Reaching High-Risk Patients for HIV Preexposure Prophylaxis
Riddell, J., & Cohn, J. A. (2016) · JAMA · doi:10.1001/jama.2016.9128 · Cited by 5
PrEParing for the Unexpected: Mechanisms and Management of HIV pre-exposure Prophylaxis Failure
Dashwood, T., & Tan, D. H. S. (2018) · Future Virology · doi:10.2217/fvl-2018-0084 · Cited by 5
Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review
Kamitani, E., Johnson, A. H., Wichser, M. E., Mizuno, Y., DeLuca, J. B., & Higa, D. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024212 · Cited by 5
Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West AfricaPreprint
Eubanks, A., Coulibaly, B., Keïta, B. D., Anoma, C., Dah, T. T. E., Mensah, E., Kaba, S., Lokrou, K. J., Ouedraogo, F. R., Badjassim, A. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1684741/v1 · Cited by 5
Psychological and Behavioural Within-participant Predictors of Adherence to Oral HIV Pre-Exposure Prophylaxis (PrEP)
Taylor, A., Hayes, R., Nwokolo, N. C., Whitlock, G. G., Dosekun, O., McCormack, S., Gafos, M., & Evangeli, M. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04151-8 · Cited by 4
Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis—A multi-methods analysis of data from a multicentre survey
Gaskins, M. D., Sammons, M. K., Kutscha, F., Nast, A., & Werner, R. N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260168 · Cited by 4
HIV PrEP access and affordability: a multidisciplinary specialty pharmacy model
Whelchel, K., Zuckerman, A. D., DeClercq, J., Choi, L., Rashid, S., & Kelly, S. G. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.11.024 · Cited by 4
Perspective Chapter: Centering Race, Stigma and Discrimination - Structural Racism and Disparities in HIV among Black Sexual Minority Men
Burns, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101528 · Cited by 4
Potential contribution of PrEP uptake by adolescents 15–17 years old to achieving the “Ending the HIV Epidemic” incidence reduction goals in the US South
Hamilton, D. T., Wang, L. Y., Hoover, K. W., Smith, D. K., Delaney, K. P., Li, J., Hoyte, T., Jenness, S. M., & Goodreau, S. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288588 · Cited by 4
Initiating pre-exposure prophylaxis in the inpatient setting: a quality improvement project
Flynn, S. J., Adamo, M., Kochanska, M., & Garcia-Grossman, I. R. (2024) · BMJ Open Quality · doi:10.1136/bmjoq-2023-002416 · Cited by 4
Exploring the Effectiveness of Pre-Exposure Prophylaxis (PrEP) Use for HIV Prevention among High-Risk Populations
Dave, P. (2024) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v12i2.1333 · Cited by 5
The Leaky Preexposure Prophylaxis Cascade—Barriers and Facilitators to Preexposure Prophylaxis Uptake and Adherence Among Youth Experiencing Homelessness in the US South: A Mixed Methods Study
Maria, D. S., Paul, M. E., Lightfoot, M. A., Nyamathi, A., Quadri, Y., Padhye, N. S., Ocampo, E., Babayev, R., Ramos, M. W., Malone-Thomas, S., et al. (2024) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000516 · Cited by 4
Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection
Kojima, N., & Klausner, J. D. (2017) · AIDS · doi:10.1097/qad.0000000000001703 · Cited by 4
Advances in research of HIV transmission networks
Dong, Z., Gao, G. F., & Lyu, F. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001155 · Cited by 6
Stimulant use interventions may strengthen ‘Getting to Zero’ HIV elimination initiatives in Illinois: Insights from a modeling study
Lee, F., Sheeler, D., Hotton, A., Vecchio, N. D., Flores, R. A., Fujimoto, K., Harawa, N. T., Schneider, J. A., & Khanna, A. S. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103628 · Cited by 4
Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis
Songtaweesin, W. N., Pornpaisalsakul, K., Kawichai, S., Wacharachaisurapol, N., Wongharn, P., Yodkitudomying, C., Panichnantakul, P., Theerawit, T., Pankam, T., & Puthanakit, T. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624211056749 · Cited by 4
Measuring Adherence to HIV Pre-Exposure Prophylaxis through Dried Blood Spots
Kumar, V. S., & Webster, M. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.253179 · Cited by 4
HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis
Hojilla, J. C., Mehrotra, M., Truong, H. M., Glidden, D. V., Amico, K. R., McMahan, V., Vlahov, D., Chariyalertsak, S., Guanira, J. V., Grant, R. M., et al. (2017) · AIDS Care · doi:10.1080/09540121.2017.1394437 · Cited by 4
Public Awareness of HIV Pre-Exposure Prophylaxis in Durham, North Carolina
Zhang, H. L., Murthy, B., Johnston, B. E., Mortiboy, M., Wu, J., Samsa, G. P., Seña, A. C., & McKellar, M. (2019) · North Carolina Medical Journal · doi:10.18043/ncm.80.1.7 · Cited by 4
COVID-19 Conspiracy Beliefs are not Barriers to HIV Status Neutral Care Among Black Cisgender Sexual Minority Men and Black Transgender Women at the Initial Peak of the COVID-19 Pandemic in Chicago, USA
Chen, Y., Duncan, D. T., Vecchio, N. D., Timmins, L., Pagkas-Bather, J., Knox, J., Lacap, S., Hanson, H., & Schneider, J. A. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03720-7 · Cited by 4
PROFILAXIA PRÉ-EXPOSIÇÃO E ENTRAVES NA PREVENÇÃO DO HIV NO BRASIL
do Nascimento, A. L. O., Silva, B. D. S., Oliveira, L. D. S., Costa, M. I., Rocha, S. B. S., & Machado, M. F. (2021) · REVISTA ELETRÔNICA EXTENSÃO EM DEBATE · doi:10.28998/rexd.v6.11534 · Cited by 4
The Relationship Between HIV Preexposure Prophylaxis Use and Laboratory-Confirmed Bacterial Sexually Transmitted Infection Positivity Among a Diverse, Multi-City Cohort of Sexually Active Sexual and Gender Minorities in the United States
Yonko, E. A., Tian, J., Aminzadeh, K., Qian, Y., Noori, G., Plankey, M. W., Friedman, M. R., Palella, F. J., Jones, D. L., Wingood, G. M., et al. (2025) · AIDS Patient Care and STDs · doi:10.1177/10872914251390196 · Cited by 3
Changes in HPV prevalence, incidence, and clearance following the use of HIV pre‐exposure prophylaxis (PrEP) among MSM in Xinjiang, China: An observational cohort study
Tian, T., Fu, L., Lu, Z., Bian, J., Zhou, X., Wang, B., Lin, Y., Zhang, Z., Liu, L., Xi, M., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29112 · Cited by 3
Predictors of PrEP Retention and Attrition in an Urban Publicly Funded Safety-net Specialty Clinic
Drezner, K., Coleman, M. E., Visconti, A., Thomas, C., Beverley, J., Harold, R. E., & Furness, B. W. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04378-z · Cited by 3
Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users
Martinson, T., Montoya, R., Moreira, C. H. V., Kuncze, K., Sassaman, K., Heise, M. J., Glidden, D. V., Amico, K. R., Arnold, E. A., Buchbinder, S., et al. (2024) · AIDS · doi:10.1097/qad.0000000000003962 · Cited by 3
PrEP Use in a US National Sample of Trans Men and Other Transmasculine People Who Have Sex With Men: A Longitudinal Analysis
Carneiro, P. B., Radix, A. E., Golub, S. A., Grosskopf, N. A., & Grov, C. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003492 · Cited by 3
Understanding Typology of Preexposure Prophylaxis (PrEP) Persistence Trajectories Among Male PrEP Users in the United States
Chen, Y.-N., Zhou, J., Kirkham, H. S., Witt, E. A., Jenness, S. M., Wall, K. M., Kamaleswaran, R., Naimi, A. I., & Siegler, A. J. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae584 · Cited by 3
Cost-effectiveness of cabotegravir versus tenofovir alafenamide plus emtricitabine versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual and other men that have sex with men
Jorgensen, P. E. W., Ruiz‐Algueró, M., Iniesta, C., Pulido, F., & Llenas‐García, J. (2025) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2024.12.023 · Cited by 3
Sexually Transmitted Infections and Sexual Healthcare of Homeless and Street-Involved Youth
Grennan, T., Edward, J., & Chown, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-40675-2_12 · Cited by 3
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)
Mayer, K. H., Yuhas, K., Amico, K. R., Wilkin, T. J., Landovitz, R. J., Richardson, P., Marzinke, M. A., Hendrix, C. W., Eshleman, S. H., Cottle, L. M., et al. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03736-z · Cited by 3
Adverse effects of daily oral pre-exposure prophylaxis in men who have sex with men and transgender women: a systematic review and meta-analysis
Pereira, M. E., de Castro, C. T., Magno, L., Oliveira, T. D. A., Soares, F., Neves, F. M. F., do Nascimento, P. R. D. S., & Dourado, I. C. (2023) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen089522 · Cited by 4
Is pre-exposure prophylaxis effective for preventing HIV infection in men who have sex with men?
Allende, R., & Acuña, M. P. (2017) · Medwave · doi:10.5867/medwave.2017.09.7117 · Cited by 3
Antiretroviral Preexposure Prophylaxis
Mayer, K. H., Krakower, D., & Boswell, S. (2016) · JAMA · doi:10.1001/jama.2016.0318 · Cited by 3
Pre-exposure Prophylaxis for HIV Infection: Preventing Disease or Promoting Sexual Health?
Valdiserri, R. O., & Holtgräve, D. R. (2019) · Journal of Community Health · doi:10.1007/s10900-018-00616-3 · Cited by 3
Correlates Associated With Willingness to Start Pre-exposure Prophylaxis Among Young Black Men Who Have Sex With Men (MSM) in Jackson, Mississippi
Ward, L. M., Bruce, M. A., Thorpe, R. J., Mena, L. A., Nunn, A. S., & Crosby, R. A. (2019) · Family & Community Health · doi:10.1097/fch.0000000000000225 · Cited by 4
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors
Janes, H., Brown, M. D., Glidden, D., Mayer, K., Buchbinder, S., McMahan, V. M., Schechter, M., Guanira, J., & Casapia, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222183 · Cited by 3
Pre-exposure prophylaxis as prevention strategy in the HIV transmission: characterization of the user
Ferreira, M. A., da Silva, N. C. R., Paula, L. D., & Andrade, H. S. (2022) · Revista Prevenção de Infecção e Saúde · doi:10.26694/repis.v8i.2220 · Cited by 3
Infección por el VIH/sida: ¿El principio del fin de la primera gran pandemia contemporánea?
Gutiérrez, F. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2017.04.004 · Cited by 3
PrEP adherence among trans women in Brazil—access needed for this key population
Wilson, E. C., Jalil, E. M., Siqueira, B. H., Moreira, R. I., Veloso, V. G., Monteiro, L., & Grinsztejn, B. G. J. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30022-4 · Cited by 3
Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence
Cheewanan, L., Manopaiboon, C., Nittaya, P., Deondara, T., Thana, K., Tharee, P., Pengnonyang, S., Pavaputanon, P., Visavakum, P., Janyam, S., et al. (2023) · AIDS Care · doi:10.1080/09540121.2022.2159312 · Cited by 2
Alcohol, Sexual Arousal, and Partner Familiarity as Predictors of Condom Negotiation: An Experience Sampling Study
Luehring‐Jones, P., Fulford, D., Palfai, T. P., Simons, J. S., & Maisto, S. A. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04189-8 · Cited by 2
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial
Cooper, S. E., Zhang, S., Haines, D., Mayer, K. H., Amico, K. R., Landovitz, R. J., Hendrix, C. W., Marzinke, M. A., Chege, W., McCauley, M., et al. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04451-7 · Cited by 2
Use of cognitive interviews to develop PrEP education for men in New York and Alabama
Brin, M., Kay, E. S., Radix, A. E., Belkind, U., Batey, D. S., Ferrara, S. A., Tanner, M. R., Galindo, C. A., Fontalvo, S., Kenniff, J., et al. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.109221 · Cited by 2

Authors: Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., Liegler, T., Rawlings, M. K., Trainor, N., Blue, R. W., Estrada, Y., Coleman, M. E., Cardenas, G., Feaster, D. J., Grant, R., Philip, S. S., Elion, R., Buchbinder, S., & Kolber, M. A.
Affiliations: University of California, San Francisco (US)
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora
Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida
National Institutes of Health (US)
DF/Net Research, Inc, Seattle, Washington
San Francisco Department of Public Health (US)
University of Michigan (US)
Gilead Sciences (United States) (US)
University of Miami (US)
Whitman-Walker Health (US)
Gladstone Institutes (US)
George Washington University (US)
Corresponding author: Liu, Albert Y.
ORCID: Liu, Albert Y.
Cohen, Stephanie E.
Vittinghoff, Eric
Anderson, Peter L.
Bacon, Oliver
Chege, Wairimu
Matheson, Tim
Amico, K. Rivet
Rawlings, M. Keith
Estrada, Yannine
Coleman, Megan E.
Feaster, Daniel J.
Grant, Robert
Philip, Susan S.
Buchbinder, Susan
Kolber, Michael A.
Venue: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2016-01-01
Volume: 176
Issue: 1
Pages: 75
ISSN: 2168-6106 (ISSN-L)
DOI: 10.1001/jamainternmed.2015.4683
PMC: PMC5042323
OpenAlex: W2173821673
Cited by: 602
References: 46
Citations by year: 2026: 12 · 2025: 29 · 2024: 42 · 2023: 45 · 2022: 57 · 2021: 47 · 2020: 68 · 2019: 87 · 2018: 83 · 2017: 71 · 2016: 57
FWCI: 55.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health
National Institute of Mental Health (R01MH095628)
National Institute of Allergy and Infectious Diseases (R01AI118575, UM1AI069496, P30AI027763, P30AI073961)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: pre-exposure prophylaxis, HIV prevention, men who have sex with men, transgender women, tenofovir disoproxil fumarate, emtricitabine, PrEP adherence, sexually transmitted infections, sexual partners, HIV acquisition, HIV testing, community health centers, STD clinics, housing stability
MeSH terms: Tenofovir, Assessment of Medication Adherence, Adenine, Adolescent, Adult, Bisexuality, Chlamydia Infections, Community Health Services, District of Columbia, Female, Florida, Gonorrhea, Humans, Male, Middle Aged, Organophosphates, Prospective Studies, San Francisco, Sexual Behavior, Syphilis, HIV Infections, Drug Monitoring, Homosexuality, Male, Anti-HIV Agents, Unsafe Sex, Medication Adherence, Young Adult, Reproductive Health, Transgender Persons, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks